This company has been marked as potentially delisted and may not be actively trading. NYSE:EXAM (EXAM) (EXAM) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About (EXAM) Stock (NYSE:EXAM) 30 days 90 days 365 days Advanced Chart Get (EXAM) alerts:Sign Up Key Stats Today's Range$35.05▼$35.1750-Day Range N/A52-Week Range$21.98▼$37.26Volume3.56 million shsAverage Volume660,679 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewExamWorks Group, Inc. is a provider of independent medical examinations (IMEs), peer reviews, bill reviews, Medicare compliance, case management and other related services (IME services or the IME industry). The Company conducts its business through four geographic segments, namely, the United States, Canada, the United Kingdom and Australia. The Company provides IME services through its medical panel of credentialed physicians and other medical providers. Its clients include property and casualty insurance carriers, law firms, third-party claim administrators and government agencies that use independent services to confirm the veracity of claims by sick or injured individuals and to facilitate care for workers' compensation, automotive, personal injury liability and disability insurance coverage. The Company also provides a range of services, including Medicare compliance services, bill review services and case management services.Read More… Receive EXAM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for (EXAM) and its competitors with MarketBeat's FREE daily newsletter. Email Address EXAM Stock News HeadlinesUTME result of biology teacher who retook the exam after first scoring 159 trendsMay 28 at 6:00 AM | msn.comCUET UG 2025 Exam: Technical glitches in CUET UG exam on May 26, students claim; delays at many centres..May 27 at 4:57 AM | msn.comEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.May 28, 2025 | Timothy Sykes (Ad)Photo: See the boy who scored 350 in the 2025 JAMB resit examMay 27 at 4:57 AM | msn.comSSC exam 2025 dates for June released at ssc.gov.in: Check complete timetable hereMay 27 at 4:57 AM | msn.comUNM engineering students take midterm exam on Rail RunnerMay 26 at 8:53 AM | msn.comJNUSU Referendum Shows Overwhelming Support To Reinstate Entrance Exam For PhD AdmissionsMay 26 at 8:53 AM | msn.comRRB NTPC CBT 1 Exam 2025 Date Revised, Check DetailsMay 25 at 6:32 PM | msn.comSee More Headlines EXAM Stock Analysis - Frequently Asked Questions How were (EXAM)'s earnings last quarter? (EXAM) (NYSE:EXAM) released its earnings results on Tuesday, May, 10th. The business services provider reported $0.08 earnings per share for the quarter, meeting the consensus estimate of $0.08. The company's revenue was up 15.4% compared to the same quarter last year. What other stocks do shareholders of (EXAM) own? Based on aggregate information from My MarketBeat watchlists, some other companies that (EXAM) investors own include Bristol-Myers Squibb (BMY), Ciena (CIEN), Best Buy (BBY), China Biologic Products (CBPO), Community Health Systems (CYH), Diplomat Pharmacy (DPLO) and Energy Transfer (ET). Company Calendar Last Earnings5/10/2016Today5/28/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorN/A Industry N/A Sub-IndustryHealth Care Services Current SymbolNYSE:EXAM CIK1498021 Webwww.examworks.com Phone+1-404-9522400FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report This page (NYSE:EXAM) was last updated on 5/28/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (EXAM) Please log in to your account or sign up in order to add this asset to your watchlist. Share (EXAM) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.